CRB
VRTX icon

Chad R. Baker’s Vertex Pharmaceuticals VRTX Stock Holding History

Chad R. Baker’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$373K Hold
750
– – 0.06% 51
2026
Q1 		$335K Hold
750
– – 0.06% 54
2025
Q4 		$340K Sell
750
-8,990
-92% -$3.87M 0.06% 56
2025
Q3 		$3.81M Hold
9,740
– – 0.66% 39
2025
Q2 		$4.34M Hold
9,740
– – 0.81% 37
2025
Q1 		$4.72M Hold
9,740
– – 0.96% 35
2024
Q4 		$3.92M Hold
9,740
– – 0.77% 39
2024
Q3 		$4.53M Buy
9,740
+4,595
+89% +$2.21M 0.89% 37
2024
Q2 		$2.41M Buy
+5,145
New +$2.23M 0.5% 41

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Chad R. Baker's VRTX Position: Q2 2026 in Review

Chad R. Baker held its Vertex Pharmaceuticals (VRTX) position steady in Q2 2026 at 750 shares worth $373K. The position accounts for 0.06% of the portfolio, ranked #51.

Chad R. Baker first reported a position in VRTX in Q2 2024 and has held it in 9 quarters since. The position peaked at $4.72M in Q1 2025. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Chad R. Baker held 750 shares of Vertex Pharmaceuticals worth $373K as of Q2 2026.
  • Chad R. Baker left its Vertex Pharmaceuticals share count unchanged in Q2 2026.
  • Vertex Pharmaceuticals made up 0.06% of Chad R. Baker's portfolio in Q2 2026, its #51 holding.
  • Chad R. Baker first reported a position in Vertex Pharmaceuticals in Q2 2024 and has held it in 9 quarters since.
  • Chad R. Baker's Vertex Pharmaceuticals position peaked at $4.72M in Q1 2025.
  • 1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Chad R. Baker's 13F filing for Q2 2026, filed 16 Jul 2026.